Let's connect

Want to discuss your project or have any questions?

Solid-state characterisation

Unlock material insights with advanced characterisation

Our highly experienced scientists can readily help you in selecting and controlling the solid state of your API.

Scientist in blue gloves adjusting a microscope in a laboratory

Polymorphism 

Nuvisan offers polymorphism studies to optimise the solid-state properties of your APIs and formulations. Our expertise helps ensure the identification, characterisation and control of polymorphic forms to enhance drug stability, solubility and bioavailability. 

  • Polymorphic screening: Systematic exploration of crystal forms under varied conditions. 
  • Advanced analytical techniques: Utilising XRPD, DSC, and microscopy for precise characterisation.
  • Form selection: Guidance on selecting the most suitable polymorph for formulation.
  • Regulatory support: Comprehensive documentation to meet regulatory requirements.
  • Integrated approach: Seamless collaboration with formulation development and manufacturing teams.

Nuvisan’s polymorphism expertise helps ensure robust and efficient development and achieve optimal product performance and regulatory success.

Salt screening

Nuvisan provides tailored salt screening studies to identify and optimise the most suitable salt form of your APIs. Our expertise helps ensure improved solubility, stability and manufacturability, to drive successful drug development. 

  • Comprehensive screening: Evaluation of a wide range of counter-ions under diverse conditions.
  • Advanced analytical techniques: Employing XRPD, NMR, DSC and solubility testing for thorough characterisation.
  • Optimised selection: Identification of the best salt form based on desired properties like stability and bioavailability.
  • Customised approach: Tailored strategies to align with your API’s unique requirements.
  • Regulatory-ready data: Complete documentation to support regulatory submissions.

At Nuvisan, we combine scientific expertise with state-of-the-art technologies to deliver high-quality salt screening services, helping ensure your API achieves its full therapeutic potential. 

 

 

XRPD testing

Nuvisan specialises in X-ray powder diffraction (XRPD) analysis, offering precise insights into the crystalline structure of pharmaceutical compounds. Our XRPD services are essential for understanding material properties, ensuring quality and supporting regulatory requirements. 

We provide:

  • Comprehensive differentiation and quantification of crystalline and amorphous phases
  • Detailed detection and characterisation of polymorphic forms for optimal form selection
  • Accurate determination of multi-phase mixture composition
  • Thorough evaluation of crystalline structure changes under diverse conditions.

Leveraging our two advanced XRPD instruments, including a GMP-qualified system, and our experienced team, Nuvisan helps ensure reliable, high-quality results to drive your development projects forward.

Contact us

Nuvisan is committed to protecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:
You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

Talk to us

talk icon
+49 731 9840 0 

Our locations

location icon

Neu-Ulm (headquarters)

Wegenerstrasse 13

89231 Neu-Ulm

Germany

Berlin

Muellerstrasse 178

13353 Berlin

Germany

Sophia Antipolis

2400 route des Colles

06410 Biot

France

Grafing

Am Feld 32

85567 Grafing

Germany

Waltrop

Im Wirrigen 25

45731 Waltrop

Germany

For concerns about pharmaceuticals or adverse drug-related events, contact us at: complaints@nuvisan.com